Exendin-4, a glucagonlike peptide1 receptor agonist, inhibits hyperglycemiainduced apoptosis in myocytes by suppressing receptor for advanced glycation end products expression

Author：          

Publisher： Spandidos Publications

ISSN： 1792-0981

Source： Experimental and Therapeutic Medicine, Vol.8, Iss.4, 2014-01, pp. : 1185-1190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pioglitazone inhibits high glucose-induced expression of receptor for advanced glycation end products in coronary artery smooth muscle cells

By            

Molecular Medicine Reports, Vol. 11, Iss. 4, 2015-01 ,pp. : 2601-2607

Spandidos Publications

Access to resources Recommend Favorite

Expression of Receptor for Advanced Glycation End Products (RAGE) is Related to Prognosis in Patients with Esophageal Squamous Cell Carcinoma

By Tateno Taro  

Annals of Surgical Oncology, Vol. 16, Iss. 2, 2009-02 ,pp. : 440-446

Springer Publishing Company

Access to resources Recommend Favorite

Significance of expression of glucagon-like peptide 1 receptor in pancreatic cancer

By                  

Oncology Reports, Vol. 34, Iss. 4, 2015-01 ,pp. : 1717-1725

Spandidos Publications

Access to resources Recommend Favorite

Litsea japonica extract inhibits neuronal apoptosis and the accumulation of advanced glycation end products in the diabetic mouse retina

By            

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 1075-1081

Spandidos Publications

Access to resources Recommend Favorite

Receptor for Advanced Glycation End Products (RAGE)—Soluble Form (sRAGE) and Gene Polymorphisms in Patients with Breast Cancer

By Tesarova Petra   Kalousova Marta   Jachymova Marie   Mestek Oto   Petruzelka Lubos   Zima Tomas  

Cancer Investigation, Vol. 25, Iss. 8, 2007-11 ,pp. : 720-725

Informa Healthcare

Access to resources Recommend Favorite